Content

Switching From Wegovy to Zepbound

Dorianne Green
Author:
Dorianne Green
Medical Writer
Dr. William Grigg
Medical Reviewer:
Dr. William Grigg
DO
The medications listed on this website are provided for informational purposes only.
Their inclusion does not guarantee they will be prescribed to any individual, as treatment decisions are ultimately at the discretion of healthcare providers. Healthcare providers may prescribe other medications, including non-stimulant options, or recommend non-pharmacological treatment based on the patient’s unique health circumstances and needs. Read more

Wegovy[1] and Zepbound[2] have a boxed warning, the most serious type of warning from the Food and Drug Administration (FDA). Zepbound’s active ingredient, tirzepatide, and Wegovy’s active ingredient, semaglutide, are contraindicated in patients with personal or family history of thyroid C-cell tumors, including medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Remember to discuss the risks with your healthcare provider.

Highlights

  • Zepbound (injections) and Wegovy (tablets or injections) are both prescription medications commonly used for weight loss.
  • Reasons you may switch from Wegovy to Zepbound include experiencing persistent, intolerable side effects or inadequate treatment results.
  • Your healthcare provider will consider many factors before recommending a switch from Wegovy to Zepbound. It’s important to determine a safe and appropriate option for you.
  • There are no published guidelines for switching from Wegovy to Zepbound, but your healthcare provider will choose the safest, personalized option and guide you through the process.

You’ve been prescribed Wegovy for weight management, but have read that Zepbound has a double-action and better results in some people. Should you consider switching?

​This article will help you understand the similarities and differences between the two medications, if it’s safe to switch, when to consider such a change, and, finally, how to switch from Wegovy to Zepbound smoothly.

Discuss available weight loss solutions with a medical provider and find out which one can help you best.

Wegovy and Zepbound: What Are They?

Wegovy (available as once-weekly injections and once-daily tablets) and Zepbound (once-weekly injections) are both prescription-only medications. They are FDA-approved for:

  • Weight loss in adults with obesity (body mass index (BMI) ≥ 30).
  • Weight loss in adults with overweight (BMI ≥ 27) plus at least one weight-related comorbid condition.
  • Treatment of moderate to severe obstructive sleep apnea in adults with obesity.

The brand name Wegovy[3] (semaglutide) was approved for chronic weight management in 2021, while Zepbound[4] (tirzepatide) was approved for the same use in 2023.

Both medications work by mimicking certain hormones in the body’s incretin system. This system regulates metabolism, slows gastric emptying, controls appetite, and stimulates insulin release in response to food intake.

Wegovy and Zepbound: What Makes Them Different?

The two important incretin hormones are GLP-1 and GIP. 

Both Wegovy (semaglutide) and Zepbound (tirzepatide) are GLP-1 receptor agonists, but Zepbound has the added benefit of[5] being a GIP receptor agonist. This dual incretin action may lead to greater weight loss for some people. In one trial, tirzepatide showed better results than semaglutide after 72 weeks. However, remember that individual responses may vary.

When it comes to unique uses of Wegovy compared to Zepbound, these include[6] :

  • Weight loss in pediatric patients aged 12 years and older who have obesity.
  • Risk reduction of heart attacks and strokes in adults with established cardiovascular disease (heart or blood vessel disease) who are obese or overweight.
  • Treatment of specific liver diseases.
"Zepbound’s dual GLP-1 and GIP activity may offer an advantage for some patients, particularly those who have plateaued on semaglutide. However, medication response is highly individualized, and the goal should be choosing the safest and most sustainable option rather than simply switching to the medication with the highest average trial results."
William S. Grigg DO
Medical provider at MEDvidi

Why Would You Switch From Wegovy to Zepbound

Although these two medications work similarly for weight loss, your body’s response to them might differ. Here are some reasons people may consider switching to another one.

Not Reaching Weight Loss Goals

About 6 out of 10 people[7] in a clinical trial lost ≥ 10% of their body weight at 72 weeks on Wegovy. The average weight loss[7] on this medication is 13.7%; some people achieve even greater weight loss while others plateau before reaching their goal. It’s also possible not to respond to the medication; in this case, it might be appropriate to consider trying Zepbound.

​In the same trial, average weight loss on Zepbound was 20.2%[7] , with 8 of 10[7] patients losing ≥ 10% body weight at 72 weeks. However, these trial results do not mean everyone will lose more weight with tirzepatide than with semaglutide.

Persistent Side Effects

Another reason for switching to a different weight loss medication is experiencing severe side effects that don’t improve. Common side effects[6] of semaglutide include:

  • nausea and vomiting
  • diarrhea or constipation
  • abdominal pain
  • headache
  • fatigue or dizziness
  • indigestion and bloating
  • belching or flatulence
  • heartburn
  • a rapid heart rate
  • sore throat

These side effects are usually dose-dependent, meaning they are worse at higher doses. Doctors get around this by starting on a low Wegovy dose and slowly increasing it, allowing the body to get used to it. Usually, these side effects are temporary, but some people just can’t tolerate semaglutide and may feel better with tirzepatide. However, note that tirzepatide has side effects too.

Get a personalized weight loss plan online from a licensed healthcare provider.

Before Switching From Wegovy to Zepbound

Make the Necessary Lifestyle Changes

“… indicated in combination with a reduced-calorie diet and increased physical activity.”

This quote is in the prescribing information for Wegovy[6] and Zepbound[2] . In other words, a healthy diet and increased exercise should be the pillars of your weight management plan before you think of switching medication.

Consult With Your Provider

You can switch from Wegovy to Zepbound if a healthcare professional thinks it’s safe and appropriate, and only under their supervision. Before making the switch, they will carefully consider your medical history and other current medications.

Find Out if You’re on the Therapeutic Dose

Semaglutide is started at a low dose that increases very slowly; some people might not see results until reaching the maintenance dose of 2.4 mg once weekly.

Consider the Cost

Cost is important if you need to self-pay or if your insurance company only covers a specific weight loss medication. Generally, Wegovy costs less than Zepbound:

Wegovy via NovoCare Pharmacy

  • 2.4 mg weekly dose = $349 per month
  • 7.2 mg weekly dose = $399 per month

Zepbound via Lilly Direct

  • 5 mg weekly dose = $399 per month
  • 10 mg weekly dose = $449 per month
  • 15 mg weekly dose = $449 per month

Another budget consideration is that, for both of these medications, the longer you take them, the better the results will be.

The Process: Switching From Wegovy to Zepbound

Currently, there are no specific guidelines for switching from Wegovy to Zepbound, but let’s look at what a healthcare professional might consider.

Do You Need to Take a Break Between the Medications?

If your healthcare provider agrees that the switch is appropriate, their priority will be your safety, so that each case might be slightly different.

  • If severe side effects of Wegovy are the trigger: Your provider may suggest a medication-free period of 2 to 4 weeks, until you settle, before starting Zepbound.
  • If you’re not losing weight despite being on the maximum Wegovy dose and don’t have side effects: Your provider may recommend starting Zepbound immediately instead of your next scheduled Wegovy injection. Note that you shouldn’t change the medication immediately unless instructed to do so.
"There is no universal conversion from Wegovy to Zepbound. In clinical practice, switching should be guided by the patient’s current dose, side effect history, appetite control, medical conditions, and overall tolerability. Starting too aggressively can increase gastrointestinal side effects, so a cautious titration plan is often the safest approach."
William S. Grigg DO
Medical provider at MEDvidi

Will You Switch to an ‘Equivalent’ Zepbound Dose?

There is no published Wegovy-to-Zepbound conversion chart, and because both these medications are associated with a high risk of side effects, a healthcare professional might be ultra-cautious during the switching process, following the recommended Zepbound dose guidelines:

  1. Starting with a low dose (2.5 mg) for at least 4 weeks.
  2. Slowly increasing to higher doses.
  3. Staying on each new dose for at least four weeks, until reaching an appropriate, therapeutic, maintenance dose of either 5, 10, or 15 mg.

After stopping Wegovy and during Zepbound titration (the process of adjusting the dosage gradually), you might experience an increased appetite and cravings for sugar and carbs.

Get personalized recommendations throughout your weight loss journey and receive your prescriptions online, if appropriate.

After the Switch From Wegovy to Zepbound

Zepbound is not a quick fix despite its dual action,so patience is the key. Always follow your provider’s guidance and take the medication as prescribed.

Follow-up Consultations

Schedule follow-ups at least every 4 weeks while your provider is increasing your Zepbound dose. At these visits, they will monitor your weight loss dynamics and ask about side effects in order to find your ideal maintenance dose.

Make Note of Side Effects

Although Zepbound is generally well tolerated, some people may experience allergic or adverse reactions.

​As with Wegovy, there are often gastrointestinal (GIT) side effects[2] such as nausea, vomiting, diarrhea, constipation, stomach pain, indigestion, tiredness, belching, and heartburn. People also commonly experience injection site reactions and hair loss[2] on Zepbound.

Tips to Manage Mild Side Effects at Home

GIT side effects are the most common. The good news is that they are usually temporary, but may reappear with each dose increase. Here are some simple dietary tips to help manage them.

  • Nausea: avoid greasy foods and eat smaller meals, more often.
  • Constipation: drink more water and eat fiber-rich foods.
  • Diarrhea: increase fluids to stay hydrated, and eat boiled chicken breasts, white rice, white bread toast, bananas, and peeled, grated apple, for a more solid stool.
  • Heartburn and Indigestion: Avoid fatty, spicy, and acidic foods, alcohol, caffeine, and don’t eat for at least 3 hours before bedtime.

For these or any other side effects that are severe, or not settling, contact your doctor immediately for advice.

Remember, Lifestyle Change is Essential

Effective weight management is only possible when the medication is combined with a healthy lifestyle. Importantly, both prescribing instructions for Wegovy and Zepbound emphasize combining them with a balanced, reduced-calorie diet and regular exercise.

Stick With It

To have lasting results, commit to taking Zepbound long-term, according to your provider’s instructions. Unfortunately, some people regain weight after stopping[8] tirzepatide, but the same is true for semaglutide[9] .

Conclusion

If you are currently using Wegovy for weight loss and dealing with side effects or are not satisfied with your results, there are other medication options available, one of which is Zepbound.

​MEDvidi’s licensed healthcare providers are an online appointment away from re-evaluating your weight loss journey and safely adjusting your treatment plan. Book a virtual weight management consultation today.

FAQ

Zepbound (tirzepatide) is not necessarily better than Wegovy (semaglutide). Even though Zepbound showed higher efficacy in some trials, this does not mean everyone will lose more weight with tirzepatide than with semaglutide. The choice depends on many individual factors, so it’s important to consult with a healthcare provider to find the right one.

Sources

hide
9 sources
  1. DailyMed - WEGOVY- semaglutide injection, solution.
    Source link
  2. HIGHLIGHTS of PRESCRIBING INFORMATION. ZEPBOUND® (tirzepatide) Injection, for subcutaneous use
    Source link
  3. HIGHLIGHTS of PRESCRIBING INFORMATION. WEGOVY (semaglutide) injection, for subcutaneous use WEGOVY (semaglutide) tablets, for oral use
    Source link
  4. HIGHLIGHTS of PRESCRIBING INFORMATION. ZEPBOUND® (tirzepatide) Injection, for subcutaneous use
    Source link
  5. Farzam K, Patel P. Tirzepatide. [Updated 2024 Feb 20]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-.
    Source link
  6. HIGHLIGHTS of PRESCRIBING INFORMATION. Accessed May 18, 2026. WEGOVY (semaglutide) injection, for subcutaneous use WEGOVY (semaglutide) tablets, for oral use
    Source link
  7. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Gomez Valderas E, Das S, Lee CJ, Glass LC, Senyucel C, Dunn JP; SURMOUNT-5 Trial Investigators. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity. N Engl J Med. 2025 Jul 3;393(1):26-36. doi: 10.1056/NEJMoa2416394. Epub 2025 May 11. PMID: 40353578.
    Source link
  8. Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA. 2023;331(1).
    Source link
  9. Wilding JPH, Batterham RL, Davies M, Van Gaal LF, Kandler K, Konakli K, Lingvay I, McGowan BM, Oral TK, Rosenstock J, Wadden TA, Wharton S, Yokote K, Kushner RF; STEP 1 Study Group. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab. 2022 Aug;24(8):1553-1564. doi: 10.1111/dom.14725. Epub 2022 May 19. PMID: 35441470; PMCID: PMC9542252.
    Source link
Show more
Dorianne Green
Author:
Dorianne Green
Medical Writer
Dr. William Grigg
Medical Reviewer:
Dr. William Grigg
DO
Share
Content
Recommended Articles
Join our newsletter

Sign up to receive mental health news and tips delivered right in your inbox every month.

Take the first step today:

book an appointment to get your symptoms assessed and obtain a prescription online.

Evidence Based

This article is based on scientific evidence, written by experts and fact checked by experts.

Our team of experts strive to be objective, unbiased, honest and to present both sides of the argument.

This article contains scientific references. The numbers
in the parentheses (1, 2, 3) are clickable links to peer-reviewed scientific papers.